Next Article in Journal
Personalized Medicine in Coronary Artery Disease: Where Are We in 2022?
Next Article in Special Issue
Swept-Source OCT Angiography Features in Patients after Macular Hole Surgery
Previous Article in Journal
Image Analysis in Digital Pathology Utilizing Machine Learning and Deep Neural Networks
Previous Article in Special Issue
Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids
 
 
Article
Peer-Review Record

Choriocapillaris Flow Deficits Quantification in Hydroxychloroquine Retinopathy Using Swept-Source Optical Coherence Tomography Angiography

J. Pers. Med. 2022, 12(9), 1445; https://doi.org/10.3390/jpm12091445
by Safa Halouani 1, Hoang Mai Le 1, Salomon Yves Cohen 1, Narimane Terkmane 2, Nabil Herda 1, Eric H. Souied 1 and Alexandra Miere 1,*
Reviewer 2:
J. Pers. Med. 2022, 12(9), 1445; https://doi.org/10.3390/jpm12091445
Submission received: 3 August 2022 / Revised: 29 August 2022 / Accepted: 30 August 2022 / Published: 1 September 2022
(This article belongs to the Special Issue Precision Medicine for Retinal Disease)

Round 1

Reviewer 1 Report

In this cross-sectional study, the authors quantitatively analyzed choriocapillaris (CC) alterations using SS-OCTA in eyes presenting with hydroxychloroquine (HCQ) toxic retinopathy and compared them to patients under HCQ without toxic retinopathy and to healthy subjects.
The manuscript is well organized and conclusions are supported by the results. The topic is appealing for the readers.
I recommend some minor revisions:
- A revision by a native English speaker should be performed.
-In the introduction, please cite the following article dealing with HCQ retinopathy (PMID 32946004)
- Line 111: Please modify with 'by using' instead of 'using'
- In the conclusion, the relatively small sample size may represent another limitation of the study. Other larger-scale studies should confirm these results. Please discuss it.

Author Response

Dear Editor,

We are grateful for the review of our manuscript entitled "Choriocapillaris flow deficits quantification in hydroxychloroquine retinopathy using swept-source optical coherence tomography angiography." The reviewers raised essential questions that we have addressed and incorporated into the revised version of the manuscript and the revised Figures and table. Please find attached the responses to the reviewers' comments. 

Author Response File: Author Response.docx

Reviewer 2 Report

The authors present an interesting study on analysis of choriocapillary flow defects in HCQ retinopathy. The manuscript is well written. 

However, one of the major drawbacks of this study is the small sample size in the toxicity sub-group. 

Second, the focal RPE thickenings in HCQ toxicity could result in shadow artifacts in the CC layer (as seen in figure 1 OCT B-scan). 

It would have been interesting to see if there were any differences between non-toxic group and normal controls. As it might help to detect preclinical toxicity. The authors should mention the post hoc p-values between these two groups.

Minor comments:

Table2:Kindly replace "Pourcentage" and "seize" with "percentage" and "size"

The labels (A, B, C, D) in figure 3 are not clear. Kindly change the color to white or place a white text box behind them.

 

Author Response

Dear Editor,

We are grateful for the review of our manuscript entitled " Choriocapillaris flow deficits quantification in hydroxychloroquine retinopathy using swept-source optical coherence tomography angiography. The reviewers raised important questions that we have addressed and incorporated into the revised version of the manuscript and the revised Figures and table. Please see the attachment for the point-by-point for reviewers' comments. 

Author Response File: Author Response.docx

Back to TopTop